Dong Zhang

Research Assistant Professor

Research Assistant Professor, Cell, Developmental, & Cancer Biology

Emailzhangdo@ohsu.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Dong Zhang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

573 Citations
10 h-Index
12 Article

p85β regulates autophagic degradation of AXL to activate oncogenic signaling
Rao, L., Mak, V. C. Y., Zhou, Y., Zhang, D., Li, X., Fung, C. C. Y., Sharma, R., Gu, C., Lu, Y., Tipoe, G. L., Cheung, A. N. Y., Mills, G. B. & Cheung, L. W. T., Dec 1 2020, In: Nature communications. 11, 1, 2291.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
Fang, Y., McGrail, D. J., Sun, C., Labrie, M., Chen, X., Zhang, D., Ju, Z., Vellano, C. P., Lu, Y., Li, Y., Jeong, K. J., Ding, Z., Liang, J., Wang, S. W., Dai, H., Lee, S., Sahni, N., Mercado-Uribe, I., Kim, T. B., Chen, K. & 7 others, Lin, S. Y., Peng, G., Westin, S. N., Liu, J., O'Connor, M. J., Yap, T. A. & Mills, G. B., Jun 10 2019, In: Cancer Cell. 35, 6, p. 851-867.e7
Research output: Contribution to journal › Article › peer-review

Open Access
40 Scopus citations
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
Sun, C., Yin, J., Fang, Y., Chen, J., Jeong, K. J., Chen, X., Vellano, C. P., Ju, Z., Zhao, W., Zhang, D., Lu, Y., Meric-Bernstam, F., Yap, T. A., Hattersley, M., O'Connor, M. J., Chen, H., Fawell, S., Lin, S. Y., Peng, G. & Mills, G. B., Mar 12 2018, In: Cancer Cell. 33, 3, p. 401-416.e8
Research output: Contribution to journal › Article › peer-review
79 Scopus citations
A murine preclinical syngeneic transplantation model for breast cancer precision medicine
Federico, L., Chong, Z., Zhang, D., McGrail, D. J., Zhao, W., Jeong, K. J., Vellano, C. P., Ju, Z., Gagea, M., Liu, S., Mitra, S., Dennison, J. B., Lorenzi, P. L., Cardnell, R., Diao, L., Wang, J., Lu, Y., Byers, L. A., Perou, C. M., Lin, S. Y. & 1 others, Mills, G. B., Apr 2017, In: Science Advances. 3, 4, e1600957.
Research output: Contribution to journal › Article › peer-review
6 Scopus citations
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers
Sun, C., Fang, Y., Yin, J., Chen, J., Ju, Z., Zhang, D., Chen, X., Vellano, C. P., Jeong, K. J., Ng, P. K. S., Eterovic, A. K. B., Bhola, N. H., Lu, Y., Westin, S. N., Grandis, J. R., Lin, S. Y., Scott, K. L., Peng, G., Brugge, J. & Mills, G. B., May 31 2017, In: Science translational medicine. 9, 392, aal5148.
Research output: Contribution to journal › Article › peer-review
68 Scopus citations

p85β regulates autophagic degradation of AXL to activate oncogenic signaling

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency

A murine preclinical syngeneic transplantation model for breast cancer precision medicine

Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers